These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Perspectives in immunotherapy of lung cancer. Hersh EM; Gutterman JU; Mavligit GM Cancer Treat Rev; 1974 Mar; 1(1):65-80. PubMed ID: 4471091 [No Abstract] [Full Text] [Related]
37. Active immunotherapy of cancer for minimal residual disease: new trends and new materials. Mathé G; Florentin I; Olsson L; Kiger N; Bruley-Rosset M; Orbach-Arbouys S; Schulz JI Prog Exp Tumor Res; 1980; 25():242-74. PubMed ID: 6986635 [No Abstract] [Full Text] [Related]
38. [Immunotherapy of carcinoma of the lung]. Sega E; Mineo TC; Rea SR; Sega FM; Ricci C Recenti Prog Med; 1978 Mar; 64(3):293-309. PubMed ID: 351751 [No Abstract] [Full Text] [Related]
39. Immunologic approaches to the management of ovarian carcinoma. Bast RC; Knapp RC Semin Oncol; 1984 Sep; 11(3):264-74. PubMed ID: 6207593 [No Abstract] [Full Text] [Related]